Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial (Q24685494)
scientific article
Language:
(P31) (Q13442814)
(P304) 242-9
(P407) (Q1860)
(P433) 2
(P478) 54
(P577) +2005-02-00T00:00:00Z
(P921) (Q101991)
(Q181600)
(Q1477)
(Q4904768)
(P1433) (Q5621669)
(P1476) "Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial" (language: en)
(P2093) E Furrie
S Macfarlane
A Kennedy
J H Cummings
S V Walsh
D A O'neil
G T Macfarlane
(P2860) (Q28218903)
(Q28144634)
(Q28593669)
(Q29619620)
(Q29617967)
(Q35596222)
(Q35563983)
(Q35217282)
(Q35168862)
(Q30927782)
(Q35103834)
(Q35051696)
(Q35595154)
(Q35594940)
(Q33423514)
(Q34104389)
(Q33600460)
(Q33815932)
(Q30581062)
(Q33872486)
(Q40826762)
(Q29028915)
(Q34407161)
(Q36364133)
(Q34528243)
(Q41725173)
(Q43086543)
(Q41705704)
(Q49169267)
(Q43945848)
(Q54762013)
(Q43363077)
(Q76593193)
(Q73118358)
(Q72688420)
(Q70823350)
(Q72998553)
(Q73837821)
(Q77494204)
(Q77494310)
(Q77763264)
other details
description scientific article

External Links